Dynavax Technologies Corporation (DVAX) Posts Q2 EPS Loss of $0.09, Revenue Tops Expectations
Dynavax Technologies Corporation (NASDAQ: DVAX) reported Q2 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $7.27 million versus the consensus estimate of $6.13 million.